-
Mashup Score: 0Challenges in Diagnosing Prurigo Nodularis and Distinguishing From Other Pruritic Conditions - 10 hour(s) ago
Melodie Young, MSN, A/GNP-C, discusses how diagnosing prurigo nodularis can be challenging due to its similarity to other pruritic conditions, and highlights the importance of recognizing key features and patient subtypes with increased prevalence to accurately differentiate it from conditions like eczema and psoriasis.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0
Haut.AI has launched the SPF Truth Booth and SPF Protection Power List, using AI to promote sun safety and personalized patient insights.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
❗For UV Safety Awareness Month, #Haut.AI has launched the SPF Truth Booth and SPF Protection Power List to show patients how skin may age with or without sunscreen and rank top formulations with science-backed grading. https://t.co/GqAH5opyeU #DermTwitter
-
-
Mashup Score: 2Upadacitinib Plus Excimer Laser Efficacious in Treating Refractory Vitiligo With Moderate to Severe Atopic Dermatitis - 14 hour(s) ago
After 4 months of treatment with the dual therapy, patients with refractory vitiligo exhibited an overall 55% remission rate.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📚 An open-label trial found that combining upadacitinib with 308-nm excimer laser therapy significantly improved repigmentation and atopic dermatitis symptoms in patients with refractory vitiligo. https://t.co/ho2mqNkLkk
-
-
Mashup Score: 2Scalp Disorders in SoC: A Diagnostic Blind Spot - 16 hour(s) ago
A systematic review reveals critical diagnostic gaps in hair loss treatment for patients with skin of color, urging improved training and protocols in dermatology.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📖 A new systematic review reveals significant diagnostic gaps in the evaluation of hair and scalp disorders in patients with skin of color, with 63% of individuals initially misdiagnosed, often delaying appropriate treatment. https://t.co/vHd9QKKxEi
-
-
Mashup Score: 0How GEP Testing is Personalizing Skin Cancer Care Beyond Staging - 18 hour(s) ago
At a recent Dermatology Times Case-Based Roundtable event, Gaurav Singh, MD, MPH, FAAD, FACMS, utilized 3 patient cases to explore the role of GEP testing in melanoma and SCC.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
⭐️ In a recent Dermatology Times Case-Based Roundtable, Gaurav Singh, MD, MPH, spotlighted the transformative impact of gene expression profile testing in personalizing skin cancer care. https://t.co/mYiYWzKdCM
-
-
Mashup Score: 2FDA News and Decisions: Midyear Updates - 20 hour(s) ago
Exclusive Report: A comprehensive look at the latest FDA approvals and pipeline developments in dermatology from the first half of 2025.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
🔓🔑✨In an exclusive midyear review, Dermatology Times highlights major FDA milestones that shaped the first half of 2025, reflecting significant momentum in the dermatologic pipeline. https://t.co/WxHjnFKUW7
-
-
Mashup Score: 3IL-23 Inhibitor Fails to Improve VASI in Pilot Trial - 1 day(s) ago
A pilot study evaluates tildrakizumab’s safety and potential in treating stable non-segmental vitiligo, highlighting the need for further research on IL-23 inhibitors.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📚 A recent pilot study explored tildrakizumab, an IL-23 inhibitor, as a treatment for stable non-segmental vitiligo, finding it safe but not significantly effective in promoting repigmentation over 24 weeks. https://t.co/4P4ceaxa5w
-
-
Mashup Score: 1Systemic Therapy for Pediatric Atopic Dermatitis: A Growing Case for Early Intervention - 2 day(s) ago
Christopher Bunick, MD, PhD, highlights how dupilumab transforms atopic dermatitis treatment in children, improving health outcomes and quality of life beyond skin symptoms.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📰 Editor in Chief Christopher Bunick, MD, PhD, emphasizes that dupilumab marks a paradigm shift in treating moderate to severe atopic dermatitis in children, offering safe, effective, long-term systemic control during critical developmental years. https://t.co/xHmp24WBas
-
-
Mashup Score: 0
A recent study reveals a significant link between alopecia areata severity and increased risk of atopic dermatitis, especially in adolescents.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📚 A large retrospective cohort study found that patients with moderate to very severe alopecia areata, especially adolescents, have significantly higher rates of comorbid atopic dermatitis compared to those with mild disease. https://t.co/PHhzF0e5T5
-
-
Mashup Score: 1Delgocitinib Cream Shows Minimal Systemic Absorption in CHE - 2 day(s) ago
Delgocitinib cream offers a safe, effective treatment for chronic hand eczema with minimal systemic absorption, ensuring no significant immunosuppressive effects.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
📚 A phase 1 study of delgocitinib cream 20 mg/g in adults with moderate to severe chronic hand eczema showed minimal systemic absorption and a favorable safety profile, with no adverse events reported. https://t.co/MtUoNEccty
-
🎥Melodie Young, MSN, A/GNP-C, shares key clinical features to help you recognize prurigo nodularis earlier, which can improve patient outcomes via faster intervention. Watch Now! https://t.co/gykQoMHJZj https://t.co/P3tozWoMoK